These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26780638)

  • 21. Single-bolus regional chemotherapy with doxorubicin versus chemoembolization in a rabbit VX2 tumor model.
    Cho SK; Shin SW; Do YS; Jang KT; Choo SW; Park KB; Park HS; Chang IS
    Diagn Interv Radiol; 2011 Dec; 17(4):374-80. PubMed ID: 21225581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation of doxorubicin-containing chitosan microspheres for transcatheter arterial chemoembolization of hepatocellular carcinoma.
    Kim JS; Kwak BK; Shim HJ; Lee YC; Baik HW; Lee MJ; Han SM; Son SH; Kim YB; Tokura S; Lee BM
    J Microencapsul; 2007 Aug; 24(5):408-19. PubMed ID: 17578731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiopaque drug-eluting beads for transcatheter embolotherapy: experimental study of drug penetration and coverage in swine.
    Dreher MR; Sharma KV; Woods DL; Reddy G; Tang Y; Pritchard WF; Chiesa OA; Karanian JW; Esparza JA; Donahue D; Levy EB; Willis SL; Lewis AL; Wood BJ
    J Vasc Interv Radiol; 2012 Feb; 23(2):257-64.e4. PubMed ID: 22178039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stabilization Improves Theranostic Properties of Lipiodol
    Deschamps F; Farouil G; Gonzalez W; Robic C; Paci A; Mir LM; Tselikas L; de Baère T
    Cardiovasc Intervent Radiol; 2017 Jun; 40(6):907-913. PubMed ID: 28271329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead.
    Poon RT; Tso WK; Pang RW; Ng KK; Woo R; Tai KS; Fan ST
    Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1100-8. PubMed ID: 17627902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Transcatheter arterial chemoembolization with doxorubicin eluting beads in the treatment of hepatocellular carcinoma].
    Sousa PF; Preto AS; Leão D; Madureira AM; Paquete J; Costa-Maia J; Vilares-Morgado P
    Acta Med Port; 2011; 24(1):29-36. PubMed ID: 21672439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Idarubicin-Loaded ONCOZENE Drug-Eluting Bead Chemoembolization in a Rabbit Liver Tumor Model: Investigating Safety, Therapeutic Efficacy, and Effects on Tumor Microenvironment.
    Borde T; Laage Gaupp F; Geschwind JF; Savic LJ; Miszczuk M; Rexha I; Adam L; Walsh JJ; Huber S; Duncan JS; Peters DC; Sinusas A; Schlachter T; Gebauer B; Hyder F; Coman D; van Breugel JMM; Chapiro J
    J Vasc Interv Radiol; 2020 Oct; 31(10):1706-1716.e1. PubMed ID: 32684417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization.
    Lewis AL; Taylor RR; Hall B; Gonzalez MV; Willis SL; Stratford PW
    J Vasc Interv Radiol; 2006 Aug; 17(8):1335-43. PubMed ID: 16923981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CalliSpheres® drug-eluting beads (DEB) transarterial chemoembolization (TACE) is equally efficient and safe in liver cancer patients with different times of previous conventional TACE treatments: a result from CTILC study.
    Zhang X; Zhou J; Zhu DD; Huang J; Sun JH; Li TF; Shi CS; Sun ZC; Hou QM; Peng ZY; Yu WQ; Ji JS; Gu WJ; Zhou GH; Xie XX; Guo XH; Cao GH; Yu ZH; Xu HH; Fang J; Ying SH; Hu WH; Ji WB; Han J; Wu X; Zheng JP; Luo J; Chen YT; Hu TY; Li L; Hu HJ; Du HJ; Shao GL
    Clin Transl Oncol; 2019 Feb; 21(2):167-177. PubMed ID: 30003530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conventional versus Drug-Eluting Bead Transarterial Chemoembolization for Neuroendocrine Tumor Liver Metastases.
    Makary MS; Kapke J; Yildiz V; Pan X; Dowell JD
    J Vasc Interv Radiol; 2016 Sep; 27(9):1298-1304. PubMed ID: 27499157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Transcatheter arterial chemoembolization with doxorubicin drug eluting beads for patients with unresectable hepatocellular carcinoma: initial experience].
    Duan F; Yan J; Liu F; Song P; Wang Y; Yuan K; Wang M
    Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):314-5. PubMed ID: 24989922
    [No Abstract]   [Full Text] [Related]  

  • 32. Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
    Liu YS; Lin CY; Chuang MT; Lin CY; Tsai YS; Wang CK; Ou MC
    BMC Gastroenterol; 2018 Aug; 18(1):124. PubMed ID: 30075752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of 70-150 μm and 100-300 μm drug-eluting bead transarterial chemoembolization for hepatocellular carcinoma.
    Deipolyi AR; Oklu R; Al-Ansari S; Zhu AX; Goyal L; Ganguli S
    J Vasc Interv Radiol; 2015 Apr; 26(4):516-22. PubMed ID: 25704226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of novel formulations for transarterial chemoembolization: combining elements of Lipiodol emulsions with Drug-eluting Beads.
    Caine M; Chung T; Kilpatrick H; Bascal Z; Willis S; Tang Y; de Baere T; Dreher M; Lewis A
    Theranostics; 2019; 9(19):5626-5641. PubMed ID: 31534507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vandetanib-eluting Radiopaque Beads: Pharmacokinetics, Safety, and Efficacy in a Rabbit Model of Liver Cancer.
    Duran R; Namur J; Pascale F; Czuczman P; Bascal Z; Kilpatrick H; Whomsley R; Ryan S; Lewis AL; Denys A
    Radiology; 2019 Dec; 293(3):695-703. PubMed ID: 31617791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doxorubicin-loaded drug-eluting beads versus conventional transarterial chemoembolization for nonresectable hepatocellular carcinoma.
    Arabi M; BenMousa A; Bzeizi K; Garad F; Ahmed I; Al-Otaibi M
    Saudi J Gastroenterol; 2015; 21(3):175-80. PubMed ID: 26021777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo evaluation of irinotecan-loaded QuadraSphere microspheres for use in chemoembolization of VX2 liver tumors.
    Tanaka K; Maeda N; Osuga K; Higashi Y; Hayashi A; Hori Y; Kishimoto K; Morii E; Ohashi F; Tomiyama N
    J Vasc Interv Radiol; 2014 Nov; 25(11):1727-35.e1. PubMed ID: 25239839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of ion exchange processes in drug-eluting embolization beads by use of an improved flow-through elution method.
    Swaine T; Tang Y; Garcia P; John J; Waters LJ; Lewis AL
    Eur J Pharm Sci; 2016 Oct; 93():351-9. PubMed ID: 27523788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics, Safety, and Efficacy of Chemoembolization with Doxorubicin-Loaded Tightly Calibrated Small Microspheres in Patients with Hepatocellular Carcinoma.
    Malagari K; Kiakidis T; Pomoni M; Moschouris H; Emmanouil E; Spiridopoulos T; Sotirchos V; Tandeles S; Koundouras D; Kelekis A; Filippiadis D; Charokopakis A; Bouma E; Chatziioannou A; Dourakis S; Koskinas J; Karampelas T; Tamvakopoulos K; Kelekis N; Kelekis D
    Cardiovasc Intervent Radiol; 2016 Oct; 39(10):1379-91. PubMed ID: 27393274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doxorubicin and mitoxantrone drug eluting beads for the treatment of experimental peritoneal carcinomatosis in colorectal cancer.
    Keese M; Gasimova L; Schwenke K; Yagublu V; Shang E; Faissner R; Lewis A; Samel S; Löhr M
    Int J Cancer; 2009 Jun; 124(11):2701-8. PubMed ID: 19165866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.